Spectrum Pharmaceuticals

.

FDA OK’s Spectrum Cancer Drug for Wider Use

Spectrum Pharmaceuticals

An Irvine drug maker, Spectrum Pharmaceuticals Inc., has said that it got regulatory approval for an expanded use of a cancer drug.

Spectrum said that the FDA approved Zevalin as an early treatment for a blood cancer, in patients with non-Hodgkin's lymphoma. The drug was used previously on patients whose tumors did not respond to other treatments.

Spectrum Pharmaceuticals inks 50:50 JV pact with Cell Therapeutics

Spectrum Pharmaceuticals inks 50:50 JV pact with Cell Therapeutics Spectrum Pharmaceuticals and Cell Therapeutics have entered into an agreement to form a 50:50 owned joint venture, RIT Oncology, to commercialize and develop Zevalin in the United States.

Latest News

Good News for the Diabetic: FDA Approved Mobile Medical Application for Sharing
Fifth Death Related to Flu in Bay Area; The  First in Napa County
Ship Industry
For Bill Erbey Its Time to Pay Back
Union Organizers Files Lawsuit Against American Airlines
Venus In Past Had Vast Oceans of Liquid Carbon Dioxide, Say Researchers
Bill and Melinda Gates Have Long term Charity Plans but Now It’s Time for Super
Wynn Everett Casino Design Have Alterations with More luxury rooms and Lesser Pa
Alert Issued after Adult Film Actor became infected with HIV
Out Look for Oil Future Remains Weak Though Brent Crude Moves Above $48
BOJ Trimmed Its Inflation Forecast and Expanded Loan Scheme Aimed at Boosting Le
Layoff Reports at DreamWorks Animation following Changes in Higher Management Le
Syndicate content